Monthly Archives: June 2015

External models of R&D innovation are the rage in Pharma today, as they should be – the future of our industry depends on a great deal more rather than less collaboration. In a very healthy way, lots of experiments are

Figuring out what disease areas are attracting the most venture funding and deal-related capital in startup and emerging biotech has historically been quite challenging as few if any datasets track it comprehensively. But late last week, on the eve of

This blog was written by Jeff Hatfield, CEO of Pennsylvania-based Vitae Pharmaceuticals, as part of the “From the Trenches” feature of LifeSciVC. Next week, BIO returns to Philadelphia for its massive annual convention, bringing together from around the world more than

This blog was written by Ankit Mahadevia, co-founder of Spero, Synlogic, and Rodin Therapeutics, as part of the “From the Trenches” feature of LifeSciVC. The concept of “getting s#it done” is central to our lives as entrepreneurs. With time and capital